[How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)]

Eolia Brissot; Tamim Alsuliman; Bérengère Gruson; Eric Hermet; Yordanka Tirefort; Ibrahim Yakoub-Agha; Sophie Alain

doi:10.1016/j.bulcan.2017.10.022

[How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)]

Bull Cancer. 2017 Dec;104(12S):S181-S187. doi: 10.1016/j.bulcan.2017.10.022. Epub 2017 Nov 21.

[Article in French]

Authors

Eolia Brissot¹, Tamim Alsuliman², Bérengère Gruson³, Eric Hermet⁴, Yordanka Tirefort⁵, Ibrahim Yakoub-Agha², Sophie Alain⁶

Affiliations

¹ Université Pierre-et-Marie-Curie, 4, place Jussieu, 75005 Paris, France; Inserm, UMRs 938, centre de Recherche Saint-Antoine, 27, rue Chaligny, 75571 Paris, France; AP-HP, hôpital Saint-Antoine, service d'hématologie clinique et thérapie cellulaire, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France. Electronic address: [email protected].
² CHU de Lille, université de Lille 2, LIRIC, Inserm U995, 59000 Lille, France.
³ CHU d'Amiens, service d'hématologie, 80054 Amiens, France.
⁴ CHU de Clermont-Ferrand, université d'Auvergne EA3846, CIC-501, hôpital Estaing, service de thérapie cellulaire et d'hématologie clinique adulte, 58, rue Montalembert, 63000 Clermont-Ferrand, France.
⁵ Hôpitaux universitaires de Genève, service d'hématologie, 4, rue Gabrielle-Perret-Gentil, 1205 Genève, Suisse.
⁶ Université de Limoges, faculté de médecine, 2, rue du docteur Marcland, 87025 Limoges, France; CHU de Limoges, service de bactériologie virologie-hygiène, 2, avenue Martin-Luther-King, 87042 Limoges, France; Centre national de référence des cytomégalovirus, 87000 Limoges, France; Inserm UMR 1092, 87000 Limoges, France.

PMID: 29169653
DOI: 10.1016/j.bulcan.2017.10.022

Abstract

The French society of bone marrow transplantation and cell therapy (SFGM-TC) organizes annually workshops in the attempt to harmonize clinical practices between different francophone transplantation center. Here, we report our recommendations regarding the management of Epstein Barr virus reactivation and lymphoproliferative disorders, cytomegalovirus (CMV) and human herpes virus 6 (HHV6) after allogeneic stem cell transplantation.

Keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; CMV; EBV; HHV-6.

Publication types

Practice Guideline
Review

MeSH terms

Cytomegalovirus / physiology*
Cytomegalovirus Infections* / diagnosis
Cytomegalovirus Infections* / therapy
Cytomegalovirus Infections* / virology
Epstein-Barr Virus Infections* / diagnosis
Epstein-Barr Virus Infections* / therapy
Epstein-Barr Virus Infections* / virology
France
Hematopoietic Stem Cell Transplantation*
Herpesvirus 4, Human / physiology*
Herpesvirus 6, Human / physiology*
Humans
Lymphoproliferative Disorders / drug therapy
Roseolovirus Infections* / diagnosis
Roseolovirus Infections* / therapy
Roseolovirus Infections* / virology
Societies, Medical
Transplantation, Homologous
Viral Load
Virus Activation*